Cargando…

Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections

Human coronavirus HKU1 (HCoV-HKU1) is one of the four endemic coronaviruses. It has been suggested that there is a difference in incidence, with PCR-confirmed HCoV-NL63 and HCoV-OC43 infections occurring more commonly, whereas HCoV-HKU1 is the least seen. Lower incidence of HCoV-HKU1 infection has a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sechan, Ferdyansyah, Grobben, Marloes, Edridge, Arthur W. D., Jebbink, Maarten F., Loens, Katherine, Ieven, Margareta, Goossens, Herman, van Hemert-Glaubitz, Susan, van Gils, Marit J., van der Hoek, Lia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093712/
https://www.ncbi.nlm.nih.gov/pubmed/35572703
http://dx.doi.org/10.3389/fmicb.2022.853410
_version_ 1784705393034788864
author Sechan, Ferdyansyah
Grobben, Marloes
Edridge, Arthur W. D.
Jebbink, Maarten F.
Loens, Katherine
Ieven, Margareta
Goossens, Herman
van Hemert-Glaubitz, Susan
van Gils, Marit J.
van der Hoek, Lia
author_facet Sechan, Ferdyansyah
Grobben, Marloes
Edridge, Arthur W. D.
Jebbink, Maarten F.
Loens, Katherine
Ieven, Margareta
Goossens, Herman
van Hemert-Glaubitz, Susan
van Gils, Marit J.
van der Hoek, Lia
author_sort Sechan, Ferdyansyah
collection PubMed
description Human coronavirus HKU1 (HCoV-HKU1) is one of the four endemic coronaviruses. It has been suggested that there is a difference in incidence, with PCR-confirmed HCoV-NL63 and HCoV-OC43 infections occurring more commonly, whereas HCoV-HKU1 is the least seen. Lower incidence of HCoV-HKU1 infection has also been observed in serological studies. The current study aimed to investigate antibody dynamics during PCR-confirmed HCoV-HKU1 infections using serum collected during infection and 1 month later. We expressed a new HCoV-HKU1 antigen consisting of both the linker and carboxy-terminal domain of the viral nucleocapsid protein and implemented it in ELISA. We also applied a spike-based Luminex assay on serum samples from PCR-confirmed infections by the four endemic HCoVs. At least half of HCoV-HKU1-infected subjects consistently showed no antibody rise via either assay, and some subjects even exhibited substantial antibody decline. Investigation of self-reported symptoms revealed that HCoV-HKU1-infected subjects rated their illness milder than subjects infected by other HCoVs. In conclusion, HCoV-HKU1 infections reported in this study displayed atypical antibody dynamics and milder symptoms when compared to the other endemic HCoVs.
format Online
Article
Text
id pubmed-9093712
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90937122022-05-12 Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections Sechan, Ferdyansyah Grobben, Marloes Edridge, Arthur W. D. Jebbink, Maarten F. Loens, Katherine Ieven, Margareta Goossens, Herman van Hemert-Glaubitz, Susan van Gils, Marit J. van der Hoek, Lia Front Microbiol Microbiology Human coronavirus HKU1 (HCoV-HKU1) is one of the four endemic coronaviruses. It has been suggested that there is a difference in incidence, with PCR-confirmed HCoV-NL63 and HCoV-OC43 infections occurring more commonly, whereas HCoV-HKU1 is the least seen. Lower incidence of HCoV-HKU1 infection has also been observed in serological studies. The current study aimed to investigate antibody dynamics during PCR-confirmed HCoV-HKU1 infections using serum collected during infection and 1 month later. We expressed a new HCoV-HKU1 antigen consisting of both the linker and carboxy-terminal domain of the viral nucleocapsid protein and implemented it in ELISA. We also applied a spike-based Luminex assay on serum samples from PCR-confirmed infections by the four endemic HCoVs. At least half of HCoV-HKU1-infected subjects consistently showed no antibody rise via either assay, and some subjects even exhibited substantial antibody decline. Investigation of self-reported symptoms revealed that HCoV-HKU1-infected subjects rated their illness milder than subjects infected by other HCoVs. In conclusion, HCoV-HKU1 infections reported in this study displayed atypical antibody dynamics and milder symptoms when compared to the other endemic HCoVs. Frontiers Media S.A. 2022-04-27 /pmc/articles/PMC9093712/ /pubmed/35572703 http://dx.doi.org/10.3389/fmicb.2022.853410 Text en Copyright © 2022 Sechan, Grobben, Edridge, Jebbink, Loens, Ieven, Goossens, van Hemert-Glaubitz, van Gils and van der Hoek. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Sechan, Ferdyansyah
Grobben, Marloes
Edridge, Arthur W. D.
Jebbink, Maarten F.
Loens, Katherine
Ieven, Margareta
Goossens, Herman
van Hemert-Glaubitz, Susan
van Gils, Marit J.
van der Hoek, Lia
Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections
title Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections
title_full Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections
title_fullStr Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections
title_full_unstemmed Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections
title_short Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections
title_sort atypical antibody dynamics during human coronavirus hku1 infections
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093712/
https://www.ncbi.nlm.nih.gov/pubmed/35572703
http://dx.doi.org/10.3389/fmicb.2022.853410
work_keys_str_mv AT sechanferdyansyah atypicalantibodydynamicsduringhumancoronavirushku1infections
AT grobbenmarloes atypicalantibodydynamicsduringhumancoronavirushku1infections
AT edridgearthurwd atypicalantibodydynamicsduringhumancoronavirushku1infections
AT jebbinkmaartenf atypicalantibodydynamicsduringhumancoronavirushku1infections
AT loenskatherine atypicalantibodydynamicsduringhumancoronavirushku1infections
AT ievenmargareta atypicalantibodydynamicsduringhumancoronavirushku1infections
AT goossensherman atypicalantibodydynamicsduringhumancoronavirushku1infections
AT vanhemertglaubitzsusan atypicalantibodydynamicsduringhumancoronavirushku1infections
AT vangilsmaritj atypicalantibodydynamicsduringhumancoronavirushku1infections
AT vanderhoeklia atypicalantibodydynamicsduringhumancoronavirushku1infections